neoadjuvant 中文意思是什麼
neoadjuvant
解釋
新輔助療法-
Neoadjuvant treatment for esophageal
食管癌的新輔助治療 -
For patients with pathologic complete response, neoadjuvant therapy may give additional benefit in prolonging overall survival
對于病理完全緩解的患者,新輔助治療可以帶來延長總體生存時間的益處。 -
However, concern has arisen regarding the potential for vascular complications due to high - dose neoadjuvant therapy before transplantation
但是,人們擔心移植前的高劑量新輔助治療有可能引發血管並發癥。 -
Liver transplantation with neoadjuvant therapy is associated with far higher rates of late arterial and portal venous complications, but these complications do not adversely affect patient and graft survival
新輔助治療后的肝移植伴發很高的遲發性動脈和門靜脈並發癥,但這些並發癥並不會對病人和移植肝的存活期產生負面影響。 -
Sixty - eight patients underwent neoadjuvant therapy and subsequent liver transplantation. arterial complications arose in 21 % ; portal venous complications arose in 22 % ; and overall, 40 % developed vascular complications
共有68例病人接受了新輔助治療並隨后進行了肝移植,其中21 %發生了動脈並發癥; 22 %發生了門靜脈並發癥;總體血管並發癥發生率為40 % 。 -
Concurrent chemoradiation has become for the 15 last years the standard treatment for locally advanced non - small cell lung cancer, either as a definite therapy in non resectable tumors, or in a neoadjuvant setting in po - tentially resectable tumors
放化療聯合應用已經成為最近15年來局部進展非小細胞肺癌的標準治療方法,既可以作為無法切除腫瘤的確切治療,又可用於有切除可能腫瘤的新輔助治療。 -
Application of neoadjuvant chemotherapy in treatment of cervical cancer
新輔助化療在宮頸癌中的應用 -
Objective : to evaluate the status quo of the application of neoadjuvant chemotherapy
目的:對新輔助化療方案的臨床應用現狀進行評價。 -
To investigate, the researchers studied stage ii and ii breast cancer patients who were receiving neoadjuvant chemotherapy
研究人員對接受新輔助化療的ii期乳腺癌患者進行了研究。 -
The most notable notion is to administer neoadjuvant chemotherapy to reduce the size of the primary tumor before surgery
其中最令人關注的主張是在手術前以新輔助化療縮小原發性腫瘤的大小。 -
Conclusion : : the multimodality treatment of stage iii and iva thymomas by means of neoadjuvant chemotherapy provides good long - term outcomes in both stages of the disease
:用新輔助化療的方法治療iii期和iva期胸腺瘤,為這兩期患者的治療提供了良好的長期的預后。 -
Results & conclusion : neoadjuvant chemotherapy play a role in the treatment of tumors, yet there is no available means to evaluate its efficacy, and further studies are needed to answer its influence on patients during operation
結果及結論:新輔助化療在腫瘤治療領域有著積極的意義,但目前尚缺少必要的手段對其療效進行評價,其對手術時間的影響也需要進一步探討。 -
New york ( reuters health ) dec 22 - positron emission tomography ( pet ) following infusion of [ 18f ] fluorodeoxyglucose ( fdg ) is an effective means of predicting response to neoadjuvant chemotherapy in patients with breast cancer, french researchers report in the december 1st issue of the journal of clinical oncology
紐約(路透社健康) 12月22日- 《臨床腫瘤學》雜志12月第1期上法國研究人員報道,對乳腺癌患者新輔助化療腫瘤的反應進行預測,正電子發射斷層攝影( pet )輸注[ 18f ]氟脫氧葡萄糖( fdg )是一種有效手段。 -
The expression of bcl - 2 and survivin protein and its relationship with therapeutic response of neoadjuvant chemotherapy in patients with breast cancer
2和生存素的表達及其與化療反應的相關性 -
Neoadjuvant chemotherapy with pirarubicin taxol regiment for the treatment of locally advanced breast cancer
方案三種化療方法治療非小細胞肺癌的療效觀察 -
Patient survival improved dramatically with advances in multiagent chemotherapy, but it was the nhi that enabled patients to complete expensive treatment courses, including preoperative neoadjuvant chemotherapy, limb - salvage surgery, and postoperative adjuvant chemotherapy
化學治療的進步大大的提高了病人的存活率,而全民健康保險的實施讓病人可以無后顧之憂的完成昂貴的療程,包括術前化療、保肢手術及術后化療。
分享友人